Zhongke Kechuang
Overview
Zhongke Kechuang is a Guangzhou-based private equity firm specializing in venture capital investments. The firm focuses on early to late-stage ventures, primarily in the biotechnology, medical, biopharma, and product research sectors. It also invests in analytics, information technology, security, retail, and internet software industries. Zhongke Kechuang has a geographical focus on China and the United States. The firm's investment strategy encompasses seed, early-stage, and late-stage ventures, with a particular emphasis on biotechnology and medical sectors. Zhongke Kechuang has made 11 investments, with its most recent being in Sitomai Medical on August 22, 2025. The firm has a history of leading investments, such as in Smart Fabric's Series C round on January 14, 2025, and in Bengbengyu's Series A round on May 15, 2024. Zhongke Kechuang's portfolio includes companies like Sitomai Medical, Smart Fabric, Bengbengyu, Hengruiyuan, NeuExcell Therapeutics, Zhongke Yuntu, Fongwell, and Jekun Auto. The firm has demonstrated a consistent investment activity, averaging approximately 0.47 rounds per year, with a follow-on index of 0.14. This indicates a strategic approach to nurturing and supporting its portfolio companies over time.
Reach Zhongke Kechuang directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Zhongke Kechuang
What sectors does Zhongke Kechuang invest in?
Zhongke Kechuang invests in Retail, Information Technology, Biotechnology, Analytics, Security and Medical, and is based in Guangdong, China. Zhongke Kechuang is listed as a private equity in the ConnectSafely investor database.
What stage does Zhongke Kechuang invest at?
Zhongke Kechuang backs companies at Seed and Early Stage.
Which regions does Zhongke Kechuang invest in?
Zhongke Kechuang invests across United States and China.
Last updated · Source: ConnectSafely investor database
